Two recent decisions by U.S. District Courts have rejected attempts to include nonconsensual third party releases in chapter 11 reorganization plans. These rulings suggest third party releases may be facing increasing push...more
3/29/2022
/ Bankruptcy Court ,
Chapter 11 ,
Commercial Bankruptcy ,
Corporate Counsel ,
Creditors ,
Debtors ,
OxyContin ,
Pharmaceutical Industry ,
Purdue Pharma ,
Reorganizations ,
Third-Party Release Agrements ,
Willful Misconduct